» Articles » PMID: 16944322

Oxidative Stress in Skin Fibroblasts Cultures of Patients with Huntington's Disease

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2006 Sep 1
PMID 16944322
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress and mitochondrial dysfunction should play a role in the neurodegeneration in Huntington's disease (HD). The most consistent finding is decreased activity of the mitochondrial complexes II/III and IV of the respiratory chain in the striatum. We assessed enzymatic activities of respiratory chain enzymes and other enzymes involved in oxidative processes in skin fibroblasts cultures of patients with HD. We studied respiratory chain enzyme activities, activities of total, Cu/Zn- and Mn-superoxide-dismutase, glutathione-peroxidase (GPx) and catalase, and coenzyme Q(10) (CoQ(10)) levels in skin fibroblasts cultures from 13 HD patients and 13 age- and sex-matched healthy controls. When compared with controls, HD patients showed significantly lower specific activities for catalase corrected by protein concentrations (P < 0.01). Oxidized, reduced and total CoQ(10) levels (both corrected by citrate synthase (CS) and protein concentrations), and activities of total, Cu/Zn- and Mn-superoxide-dismutase, and gluthatione-peroxidase, did not differ significantly between HD-patients and control groups. Values for enzyme activities in the HD group did not correlate with age at onset and of the disease and with the CAG triplet repeats. The primary finding of this study was the decreased activity of catalase in HD patients, suggesting a possible contribution of catalase, but not of other enzymes related with oxidative stress, to the pathogenesis of this disease.

Citing Articles

Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.

Fatima J, Siddique Y CNS Neurol Disord Drug Targets. 2024; 23(10):1217-1233.

PMID: 38288843 DOI: 10.2174/0118715273283338240104112106.


Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases.

Tang L, Liu S, Li S, Chen Y, Xie B, Zhou J Int J Mol Sci. 2023; 24(12).

PMID: 37373274 PMC: 10299044. DOI: 10.3390/ijms241210127.


Alpha-Pinene Alleviates Motor Activity in Animal Model of Huntington's Disease via Enhancing Antioxidant Capacity.

Rahmani H, Moloudi M, Hashemi P, Hassanzadeh K, Izadpanah E Neurochem Res. 2023; 48(6):1775-1782.

PMID: 36689085 DOI: 10.1007/s11064-023-03860-9.


Proteomic Profiling Reveals Increased Glycolysis, Decreased Oxidoreductase Activity and Fatty Acid Degradation in Skin Derived Fibroblasts from LHON Patients Bearing m.G11778A.

Yao S, Zhang X, Jin X, Yang M, Li Y, Yang L Biomolecules. 2022; 12(11).

PMID: 36358916 PMC: 9687919. DOI: 10.3390/biom12111568.


The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Olesen M, Villavicencio-Tejo F, Quintanilla R Transl Neurodegener. 2022; 11(1):36.

PMID: 35787292 PMC: 9251940. DOI: 10.1186/s40035-022-00308-y.


References
1.
Bossi S, Simpson J, Isacson O . Age dependence of striatal neuronal death caused by mitochondrial dysfunction. Neuroreport. 1993; 4(1):73-6. DOI: 10.1097/00001756-199301000-00019. View

2.
Flohe L, Gunzler W . Assays of glutathione peroxidase. Methods Enzymol. 1984; 105:114-21. DOI: 10.1016/s0076-6879(84)05015-1. View

3.
Schilling G, Savonenko A, Coonfield M, Morton J, Vorovich E, Gale A . Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Exp Neurol. 2004; 187(1):137-49. DOI: 10.1016/j.expneurol.2004.01.003. View

4.
Santamaria A, Perez-Severiano F, Rodriguez-Martinez E, Maldonado P, Pedraza-Chaverri J, Rios C . Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease. Neurochem Res. 2001; 26(4):419-24. DOI: 10.1023/a:1010911417383. View

5.
Koroshetz W, Jenkins B, Rosen B, Beal M . Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol. 1997; 41(2):160-5. DOI: 10.1002/ana.410410206. View